Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic LeukemiaFrancesco Lo‐Coco, Uwe Platzbecker, Paola Fazi et al.|New England Journal of Medicine|2013Cited by 1.6k
Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study GroupJan Krönke, Konstanze Döhner, Richard F. Schlenk et al.|Journal of Clinical Oncology|2011Cited by 393
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureMohammed Wattad, Daniela Weber, Konstanze Döhner et al.|Leukemia|2017Cited by 118
Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III StudyRichard F. Schlenk, Hartmut Döhner, Peter Paschka et al.|Journal of Clinical Oncology|2019Cited by 111